No Data
No Data
Viking Therapeutics Stock On Brink Of Death Cross As Weight Loss Hype Loses Momentum
Here's Yet Another Reason to Buy Viking Therapeutics Stock Like There's No Tomorrow
Will weight loss drugs be included in the US medical insurance, becoming the strongest "roadblock" for the Trump team?
The "Dual Weight Loss Champions" led the significant rise.
BTIG Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $125
Amgen Obesity Drug Falls Short of Efficacy Expectations in Trial, Mizuho Says; Shares Decline
H.C. Wainwright Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $102
No Data
No Data
